Cognitive behavioral therapy and pharmacotherapy for anxiety: Treatment preferences and credibility among pregnant and non-pregnant women
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Behaviour Research and Therapy
- Vol. 52, 53-60
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Are exposure-based cognitive behavioral therapies safe during pregnancy?Archives of Women's Mental Health, 2012
- Patient Preferences for Obsessive-Compulsive Disorder TreatmentThe Journal of Clinical Psychiatry, 2010
- The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic reviewGeneral Hospital Psychiatry, 2010
- Providing a treatment rationale for PTSD: Does what we say matter?Behaviour Research and Therapy, 2009
- What you believe is what you want: Modeling PTSD-related treatment preferences for sertraline or prolonged exposureJournal of Behavior Therapy and Experimental Psychiatry, 2009
- Cross-National Associations Between Gender and Mental Disorders in the World Health Organization World Mental Health SurveysArchives of General Psychiatry, 2009
- What would you choose? Sertraline or prolonged exposure in community and PTSD treatment seeking womenDepression and Anxiety, 2009
- Women’s Attitudes, Preferences, and Perceived Barriers to Treatment for Perinatal DepressionBirth, 2009
- Computer-assisted delivery of cognitive behavioral therapy for anxiety disorders in primary-care settingsDepression and Anxiety, 2009
- Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005